PMID- 14668952
OWN - NLM
STAT- MEDLINE
DCOM- 20040610
LR  - 20181130
IS  - 0214-0934 (Print)
IS  - 0214-0934 (Linking)
VI  - 16
IP  - 8
DP  - 2003 Oct
TI  - Cardiovascular research in Australia.
PG  - 540-50
AB  - The Baker Heart Research Institute (BHRI), one of Australia's finest research 
      facilities, played host to the 27th annual Australasian Section of the 
      International Society for Heart Research meeting, New Science at the Heart of New 
      Therapies, August 7-9, 2003. This report discusses the keynote lectures 
      (Prophylactic Effects of Statins on Ischaemic Heart Disease, Diet and Wine as 
      Cardioprotection, Artificial Heart Technology and Therapeutics) and the symposia 
      presented at the meeting. The topics for the symposia were vascular regulatory 
      mechanisms, adaptation and regulation of myocardial metabolism, signaling and 
      mechanisms in hypertrophy/fibrosis, gender and cardiovascular disease and the 
      dilemma of diabetes. The high standard of the presented material clearly 
      demonstrates the strength that Australia in general and the BHRI in particular 
      have in cardiovascular research.
FAU - Doggrell, Sheila A
AU  - Doggrell SA
AD  - Doggrell Biomedical Communication, Lynfield, Auckland, New Zealand. 
      s_doggrell@yahoo.com
LA  - eng
PT  - Congress
PL  - United States
TA  - Drug News Perspect
JT  - Drug news & perspectives
JID - 8809164
SB  - IM
MH  - Australia
MH  - Cardiovascular Diseases/*therapy
MH  - Humans
MH  - Research
EDAT- 2003/12/12 05:00
MHDA- 2004/06/21 10:00
CRDT- 2003/12/12 05:00
PHST- 2003/12/12 05:00 [pubmed]
PHST- 2004/06/21 10:00 [medline]
PHST- 2003/12/12 05:00 [entrez]
AID - 424 [pii]
PST - ppublish
SO  - Drug News Perspect. 2003 Oct;16(8):540-50.